Cite
MLA Citation
Simone Maarup et al.. “CTIM-22. NIVOLUMAB AND BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA; T-CELL REACTIVITY AGAINST AUTOLOGOUS TUMOR CELLS.” Neuro-oncology, vol. 23, 2021, pp. vi54–vi55. http://access.bl.uk/ark:/81055/vdc_100146089652.0x00001b